Date/Time
Date(s) - November 12, 2024 - November 15, 2024
7:00 am - 12:00 pm
Categories
Hosted by Windshire’s President, James Blackwell
Certified through: The Center for Professional & Innovation & Education (CfPIE) (please hyperlink to website: https://www.cfpie.com/
Dates: November 12 – 15, 2024 (7:00 AM to 12:00 PM ET / 1:00 PM to 6:00 PM CET)
Join us for a comprehensive 20-hour course on CMC Regulatory Compliance Strategy for Recombinant Proteins, Monoclonal Antibodies, & Biosimilars, hosted by Windshire’s president, James Blackwell. This course is designed to help professionals involved with recombinant proteins and monoclonal antibodies (including fusion proteins, bispecific antibodies, and antibody-drug conjugates) develop an effective risk-based Chemistry, Manufacturing & Control (CMC) regulatory compliance strategy for the manufacture and control of these products.
Don’t miss this opportunity to enhance your expertise in the manufacturing and control of recombinant proteins, monoclonal antibodies, and biosimilars. Register here: https://www.cfpie.com/course/cmc-regulatory-compliance-for-biopharmaceuticals-and-biosimilars